These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18603150)

  • 1. Safety of aprotinin (again).
    Casati V; Romano A; D'Angelo A
    Lancet; 2008 Jul; 372(9632):27. PubMed ID: 18603150
    [No Abstract]   [Full Text] [Related]  

  • 2. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Yasim A; Aşik R; Atahan E
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
    Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
    Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
    Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Body SC; Mazer CD
    Anesth Analg; 2006 Dec; 103(6):1354-9. PubMed ID: 17122202
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro: tranexamic acid is better than aprotinin in decreasing bleeding after cardiac surgery.
    Guenther CR
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):471-3. PubMed ID: 7524719
    [No Abstract]   [Full Text] [Related]  

  • 9. Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery.
    Murkin JM
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):474-6. PubMed ID: 7524720
    [No Abstract]   [Full Text] [Related]  

  • 10. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 11. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic drugs.
    Mannucci PM
    N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic methods to reduce perioperative bleeding.
    Levy JH
    Transfusion; 2008 Mar; 48(1 Suppl):31S-38S. PubMed ID: 18302580
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
    Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of non-transfusional haemostatic agents.
    Cattaneo M; Mannucci PM
    Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
    [No Abstract]   [Full Text] [Related]  

  • 18. The current place of aprotinin in the management of bleeding.
    Royston D
    Anaesthesia; 2015 Jan; 70 Suppl 1():46-9, e17. PubMed ID: 25440394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tranexamic acid with aprotinin in pediatric cardiac surgery.
    Chauhan S
    Ann Card Anaesth; 2015; 18(1):27-8. PubMed ID: 25566707
    [No Abstract]   [Full Text] [Related]  

  • 20. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
    Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
    Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.